Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease-Reference-Cited by-同舟云学术

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease

Published:2017-06-29 Issue:1 Volume:12 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Albiñana Virginia,Escribano Rosa María Jiménez,Soler Isabel,Padial Luis Rodríguez,Recio-Poveda Lucia,Villar Gómez de las Heras Karina,Botella Luisa María

Funder

Consejo Superior de Investigaciones Científicas

Alianza VHL Spain

Fundación Iberdrola

Bodegas Protos

CIBERER IS CARLOS III SPAIN

FUNDACIÓN PORT AVENTURA

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-017-0664-7.pdf

Reference39 articles.

1. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical Features and Natural History of von Hippel-Lindau Disease. Q J Med. 1990;283:1151–63.

2. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. Von Hippel-Lindau disease. Lancet. 2003:2059–67.

3. González Escobar AB, Morillo Sánchez MJ, García-Campos JM. Enfermedad de Von Hippel Lindau: estudio familiar. Arch Soc Esp Oftalmol. 2012;87(11):368–72.

4. Richard S, Gardie B, Couvè S, Von Hippel-Lindau GS. How a rare disease illuminates cancer biology. Semin Cancer Biol. 2013;23:26–37.

5. Chan CC, Collins ABDCE. molecular pathology of eyes with von hippel–lindau (vhl) disease a review. Retina. 2007;27(1):1–7.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinal Hemangioblastomas;Von Hippel-Lindau Disease;2024

2. Proteostasis Modulation in Germline Missense von Hippel Lindau Disease;Clinical Cancer Research;2023-04-05

3. β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding;International Journal of Molecular Sciences;2023-02-28

4. Revisiones sistemáticas en cinco pasos: IV. Cómo sintetizar los resultados;Medicina de Familia. SEMERGEN;2022-11

5. Drug repurposing as a current strategy in medicine discovery;Medicina de Familia. SEMERGEN;2022-11